Anatibant
Anatibant (LF 16-0687; XY-2405) is a selective non-peptide bradykinin B2 receptor antagonist. Anatibant binds to the human, rat and guinea-pig recombinant B2 receptor with Ki values of 0.67 nM, 1.74 nM and 1.37 nM, respectively. Anatibant crosses the blood-brain barrier (BBB). Anatibant can be used in research on brain damage diseases.
For research use only. We do not sell to patients.
- CAS No.: 209733-45-9
- Formula: C34H36Cl2N6O5S
- Molecular Weight:711.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
![[Des-Arg9]-Bradykinin acetate](https://file.medchemexpress.com/product_pic/hy-p0298a.gif)
HY-P0298A
[Des-Arg9]-Bradykinin acetateBradykinin Receptor Agonist -
HY-P1484
Bradykinin (1-7)Bradykinin Receptor Modulator -
HY-147273
FulimetibantBradykinin Receptor Antagonist -
HY-P1469
Bradykinin (1-6)Bradykinin Receptor Modulator -
![[Hyp3]-Bradykinin](https://file.medchemexpress.com/product_pic/hy-p3061.gif)
HY-P3061
[Hyp3]-BradykininBradykinin Receptor Agonist -
HY-P1490
Bradykinin (2-9)Peptide -
![[Des-Arg9]-Bradykinin](https://file.medchemexpress.com/product_pic/hy-p0298.gif)
HY-P0298
[Des-Arg9]-BradykininBradykinin (B1) Receptor Agonist
All Bradykinin Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
[2]|
Bradykinin B2 Receptor (B2R) 0.67 nM (Ki, human recombinant B2 receptor) |
Bradykinin B2 Receptor (B2R) 1.74 nM (Ki, Rat recombinant B2 receptor) |
Bradykinin B2 Receptor (B2R) 1.37 nM (Ki, Guinea-pig recombinant B2 receptor) |
In Vitro
Anatibant binds to the native bradykinin B2 receptor from human umbilical vein (HUV), rat uterus (RU) and guinea-pig ileum (GPI) giving Ki values of 0.89 nM, 0.28 nM and 0.98 nM, respectively[2].
Anatibant inhibits bradykinin-induced IP1, IP2 and IP3 formation in INT407 cells yielding pKB values of 8.5, 8.6 and 8.7, respectively[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57/Bl6 mice (25-28 g) were subjected to Controlled Cortical Impact trauma (CCI)[1]
-
Dosage:3 mg/kg
-
Administration:Subcutaneous bolus; injection 15 min and 8 h after trauma, respectively
-
Result:Demonstrated a significant reduction of ICP and of contusion volume 24 h after trauma in treated mice.
Chemical Information
-
CAS No. 209733-45-9
-
Molecular Weight 711.66
-
Formula C34H36Cl2N6O5S
-
SMILES
O=C(NCCCNC(C1=CC=C(C=C1)C(N)=N)=O)[C@H]2N(CCC2)S(=O)(C3=CC=C(C(COC4=C5N=C(C=C(C5=CC=C4)C)C)=C3Cl)Cl)=O
-
Synonyms
LF 16-0687; XY-2405
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Klaus Zweckberger, et al. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. Neurosci Lett. 2009 Apr 24;454(2):115-7. [Content Brief]
[2]. D Pruneau, et al. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist. Immunopharmacology. 1999 Sep;43(2-3):187-94. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anatibant Related Classifications
HY-121156 Related Classifications
Powered by Bioz